ITUB:NYSEItau Unibanco Banco Holding SA Analysis
Data as of 2026-04-11 - not real-time
$9.16
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Itaú Unibanco (ITUB) trades at a forward P/E of about 11.6, well below the industry average of 17.1, suggesting a valuation edge. The bank delivers solid fundamentals with 11% revenue growth, a 21% ROE and a dividend yield of 1.15% backed by a 76% payout ratio. Technicals show a bullish MACD (line above signal) and an RSI of 65, indicating momentum but also proximity to overbought territory. The stock sits near its recent resistance of $9.22, just above the current price of $9.16, while support lies around $7.79, framing a modest upside potential. Volatility is elevated at roughly 44% over the past 30 days and beta hovers near 1.0, reflecting sensitivity to market swings. Volume trends are decreasing, which may temper short‑term liquidity. Despite a negative operating cash flow, the balance sheet is strong, with over $480B in cash offsetting $1.07T of debt. The upside/downside projection is –9%, hinting at limited near‑term upside. Overall, the combination of undervalued pricing, robust earnings, and a steady dividend makes ITUB attractive for patient investors, though macro‑economic and currency headwinds in Brazil warrant caution.
In the short run, the stock’s proximity to resistance and high volatility suggest a hold stance, while the medium to long horizon benefits from its value tilt, growth metrics, and dividend sustainability. Investors should monitor Brazilian regulatory developments and currency dynamics, but the current risk‑reward profile leans toward a buy recommendation for those with a medium‑to‑long term horizon.
In the short run, the stock’s proximity to resistance and high volatility suggest a hold stance, while the medium to long horizon benefits from its value tilt, growth metrics, and dividend sustainability. Investors should monitor Brazilian regulatory developments and currency dynamics, but the current risk‑reward profile leans toward a buy recommendation for those with a medium‑to‑long term horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance at $9.22
- High 30‑day volatility (~44%)
- Bullish MACD but RSI approaching overbought
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued P/E relative to industry
- Strong ROE (21%) and revenue growth (11%)
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust cash position offsetting debt load
- Consistent earnings generation and dividend track record
- Long‑term exposure to Brazil’s large consumer market
Key Metrics & Analysis
Financial Health
Revenue Growth11.00%
Profit Margin32.28%
P/E Ratio11.6
ROE21.01%
ROA1.55%
P/B Ratio2.5
Op. Cash Flow$-25275000832
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI65.3
Support$7.79
Resistance$9.22
MA 20$8.27
MA 50$8.64
MA 200$7.37
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Target Price$8.33
Upside/Downside-9.05%
GradeUndervalued
TypeBlend
Dividend Yield1.15%
Risk Assessment
Beta1.04
Volatility43.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.